In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection

BACKGROUND: Clostridium difficile infection is the leading cause of hospital-acquired gastrointestinal infection and incidence rates continue to rise. Clostridium difficile infection is becoming increasingly complex to treat owing to the rise in treatment failures and recurrent infections. There is...

Descripción completa

Detalles Bibliográficos
Autores principales: Roder, Christine, Athan, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419417/
https://www.ncbi.nlm.nih.gov/pubmed/32377889
http://dx.doi.org/10.1007/s40268-020-00306-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419417/
https://www.ncbi.nlm.nih.gov/pubmed/32377889
http://dx.doi.org/10.1007/s40268-020-00306-3

Ejemplares similares